X-77688876-T-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PP2PP3_ModeratePP5_Very_Strong
The ENST00000373344.11(ATRX):c.536A>G(p.Asn179Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 23)
Consequence
ATRX
ENST00000373344.11 missense
ENST00000373344.11 missense
Scores
8
6
2
Clinical Significance
Conservation
PhyloP100: 7.67
Genes affected
ATRX (HGNC:886): (ATRX chromatin remodeler) The protein encoded by this gene contains an ATPase/helicase domain, and thus it belongs to the SWI/SNF family of chromatin remodeling proteins. This protein is found to undergo cell cycle-dependent phosphorylation, which regulates its nuclear matrix and chromatin association, and suggests its involvement in the gene regulation at interphase and chromosomal segregation in mitosis. Mutations in this gene are associated with X-linked syndromes exhibiting cognitive disabilities as well as alpha-thalassemia (ATRX) syndrome. These mutations have been shown to cause diverse changes in the pattern of DNA methylation, which may provide a link between chromatin remodeling, DNA methylation, and gene expression in developmental processes. Multiple alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 15 ACMG points.
PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in ENST00000373344.11
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), ATRX. . Gene score misZ 3.1025 (greater than the threshold 3.09). GenCC has associacion of gene with alpha thalassemia-X-linked intellectual disability syndrome, ATR-X-related syndrome, intellectual disability-hypotonic facies syndrome, X-linked, 1.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.93
PP5
Variant X-77688876-T-C is Pathogenic according to our data. Variant chrX-77688876-T-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 93141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-77688876-T-C is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATRX | NM_000489.6 | c.536A>G | p.Asn179Ser | missense_variant | 7/35 | ENST00000373344.11 | NP_000480.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATRX | ENST00000373344.11 | c.536A>G | p.Asn179Ser | missense_variant | 7/35 | 1 | NM_000489.6 | ENSP00000362441 | P3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD4 exome Cov.: 29
GnomAD4 exome
Cov.:
29
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Alpha thalassemia-X-linked intellectual disability syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Jan 01, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Mar 22, 2022 | Same or different nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000093141, PMID:10995512). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 16813605). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.745>=0.6, SPLICEAI: 0.68). A missense variant is a common mechanism . It is not observed in the gnomAD v2.1.1 dataset. Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 03, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 02, 2016 | The c.536 A>G pathogenic variant in the ATRX gene has been reported previously in association with ATRX-related disorders (Picketts et al., 1996; Badens et al., 2006; Wada et al., 2000). It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Functional studies indicate that c.536 A>G creates a cryptic splice donor site, leading to a deletion of 63 nucleotides (reported as A751G using alternate nomenclature in Villard et al., 1997; reported as A869G using alternate nomenclature in Picketts et al., 1996). This substitution occurs in the ADD domain and pathogenic variants affecting this domain are presumed to have structural consequences on the ATRX protein and impact histone methylation (Argentaro et al., 2007; Iwase et al., 2011; Stenson et al., 2014). - |
Intellectual disability-hypotonic facies syndrome, X-linked, 1 Pathogenic:2
Pathogenic, criteria provided, single submitter | research | HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology | Jun 25, 2019 | - - |
Likely pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | May 04, 2022 | The hemizygous p.Asn179Ser variant in ATRX was identified by our study in 3 siblings with x-linked mental retardation-hypotonic facies syndrome. This variant is assumed de novo in 1 individual, but maternity and paternity have not been confirmed (PMID: 16813605). The variant has been reported in at least 5 individuals of Japanese and unknown ethnicity with x-linked mental retardation-hypotonic facies syndrome (PMID: 16813605, 10995512, 8968741, 25252072, 33229608), but was absent from large population studies. This variant has also been reported in ClinVar (Variation ID: 93141) as pathogenic by GeneDx, HudsonAlpha Institute for Biotechnology, and EGL Genetic Diagnostics, Eurofins Clinical Diagnostics. In vitro functional studies provide some evidence that the p.Asn179Ser variant may slightly impact protein function (PMID: 8968741). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The number of missense variants reported in ATRX in the general population is lower than expected, suggesting there is little benign variation in this gene and slightly increasing the possibility that a missense variant in this gene may not be tolerated. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PM2, PM6, PP2, PP3, PS4_supporting, PS3_supporting (Richards 2015). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;.;T;T;.;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;.;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;.;.;.;.
REVEL
Pathogenic
Sift
Uncertain
D;D;.;.;.;.
Sift4G
Pathogenic
D;D;D;.;D;D
Polyphen
P;.;.;.;.;.
Vest4
MutPred
Gain of helix (P = 0.062);.;.;Gain of helix (P = 0.062);.;.;
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 5
Find out detailed SpliceAI scores and Pangolin per-transcript scores at